Having trouble viewing this email? View in your browser.
ESCMID Logo

3 July 2018
WEEKLY NEWS

Dear colleagues,

Please find below the latest edition of ESCMID Weekly News.

With kind regards,

ESCMID Executive Office.

 

Nominations for the TAE Steering Committee open this Friday

In 2018 we are looking for new Trainee Association of ESCMID Steering Committee members with a background in Clinical Microbiology. The vacancies are for a three-year term starting in January 2019 and are to be filled with new members who will be elected in Autumn 2018. You can view the criteria here. The nomination platform will open this Friday (6 July) and remain open until 17 September. Don`t miss this chance to be a part of a dynamic and international team of young scientists!

› Read more
 

CMI Highlight: Four-year safety follow-up of the tetravalent dengue vaccine efficacy randomized controlled trials in Asia and Latin America

A recombinant, live, attenuated, tetravalent dengue vaccine (CYD-TDV) was previously shown efiicient against virologically confirmed dengue (VCD). In this study, Arredondo-García and colleagues performed a long-term follow-up to monitor the incidence of VCD-hospitalization and severe VCD-hospitalization in five Asian-Pacific countries, five Latin American countries and in Thailand. Overall analyses including participants of all ages showed a reduction in the number of hospitalized VCD cases in vaccinated participants.

› Read more
 

Postgraduate Education Course, Grenoble

Don’t miss out on your chance to enrol in the postgraduate education workshop 'Infections in the Elderly: The Next Challenges', held in Grenoble, France, from 12 - 14 September 2018. The unique challenges, considerations and specifics of treating infectious diseases in elderly patients will be addressed by an engaging faculty of experts in the field.

› Read more
 

Postgraduate Education Course, Lausanne

The ESCMID Course 'Diagnostic Microbiology: MALDI-TOF, Bacterial Genomics, Metagenomics, Automation and Molecular Microbiology' is being held in Lausanne, Switzerland from 25-28 September, 2018. This course represents a fantastic opportunity for microbiologists and other diagnostic professionals to exchange knowledge and ideas on the present and future of diagnostic microbiology.

› Read more
 

ESCMID/ASM Conference Update

We are preparing for the ‘Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance’ with our colleagues from the American Society of Microbiology, to be held in Lisbon this September.

We are currently collating the abstract program, having received close to 150 abstracts from 44 countries (top submitters were USA, UK, Nigeria and Turkey).

Registrations are still available here.

› Read more
 

Grant applications open for Cuba 2018

ESCMID is offering 10 grants to cover the cost of registration for deserving applicants for the course 'Conference on Antimicrobial Resistance: From Bench to Practice'. To apply, please write 100 words or less describing why it would be beneficial for you to attend the conference with the support of the ESCMID grant. After the selection process has been completed, applicants showing the ability to be in Havana at the time of the conference will have their registration fee paid for by ESCMID. Entries may be directed to Carla Seiler: cubaconf2018@escmid.org

› Read more
ESCMID Executive Office
P.O. Box 214
4010 Basel
Switzerland
Phone +41 61 5080 173
info@escmid.org
www.escmid.org
Follow ESCMID
Visit us on LinkedIn Visit us on YouTube
 
The ESCMID Newsletter is issued on behalf of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) by the ESCMID Executive Office. It contains announcements of ESCMID-related matters and other information of interest to professionals in the infection field.

Tip: To ensure that you receive the ESCMID newsletter in your inbox, add newsletter@escmid.org to your email program’s address book.

You have received this email as a contact of ESCMID or one of its affiliated societies. You can unsubscribe or change your newsletter subscriptions here.